Clinical Trial Update: Sequential Therapy in Multiple Myeloma Guided by MRD Assessments [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in multiple myeloma is evaluating sequential therapy guided by minimal residual disease (MRD) assessments. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING